Re: Farmas USA
Echale un vistazo, aqui hay algo gordo, yo estoy dentro aunque entre un poco subido, viene de una subida de 5,25 a 14,70, aprovacion provisional de un farmaco tien FDA en octubre,S2
http://www.google.com/finance?q=SUPN
Supernus Pharmaceuticals, Inc. (Supernus) is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Supernus is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder (ADHD). Supernus’s two epilepsy product candidates are SPN-538 and Epliga. Epliga is in Phase III clinical trials. Supernus ADHD product candidates include SPN-810 (molindone hydrochloride), a treatment for impulsive aggression in patients with ADHD, and SPN-812, a non-stimulant treatment for ADHD. Both of these programs are in Phase II. In addition to these four products candidates, Supernus has several additional product candidates in various stages of development, including SPN-809. Its wholly owned subsidiary includes TCD Royalty Sub LLC.
p.d. me puedes traducir esto, estoy rellenando el impreso para cambiar los valores a IB y no me lo traduce google,gracias CLEARSTREAM